Who invested in Lysosomal Therapeutics?
Lysosomal Therapeutics's investors include Atlas Venture, Hatteras Venture Partners, Roche Venture Fund, Partners HealthCare Innovation and Lilly Ventures, and 3 more on record.
United States · Series A startup
2 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$25Mraised across 2 rounds since 2014, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $10M sold, first sale Jan 2015
From a historical funding recordSEC filing: $4.8M sold, first sale Apr 2014
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Lysosomal Therapeutics's investors include Atlas Venture, Hatteras Venture Partners, Roche Venture Fund, Partners HealthCare Innovation and Lilly Ventures, and 3 more on record.
Lysosomal Therapeutics has raised $25M across 2 rounds since 2014.
Lysosomal Therapeutics's most recent round was a Series A of $20M in Feb 2015.
Its most recent round, $20M in Feb 2015, is also its largest on record.
Lysosomal Therapeutics's first round on record, in May 2014, was backed by Atlas Venture, Hatteras Venture Partners and Roche Venture Fund and 4 others.
Lysosomal Therapeutics's latest named round is a Series A, in Feb 2015.
Lysosomal Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.